Davis Polk advised the representatives of the several underwriters in the offering. Aziyo Biologics, Inc. completed the $50 million initial public offering of common stock. The…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
